AMOREPACIFIC Ventures
VC Fund
Seoul, South Korea
AMOREPACIFIC Ventures is a VC fund in Seoul focused on Beauty and Retail. AMOREPACIFIC Ventures is the AMOREPACIFIC group’s corporate venture capital arm. They invest in early and later stage opportunities which are strategically relevant to AMOREPACIFIC.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries AMOREPACIFIC Ventures invests in
Stages AMOREPACIFIC Ventures invests in
Countries AMOREPACIFIC Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Mike Kim
|
|||
Paul Kang
|
|||
|
Tim Kim
|
|||
Investment Focus
Industry
- Beauty 1 (33%)
- Retail 1 (33%)
- Fashion 1 (33%)
- Medical 1 (33%)
- Big Data 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Funding Round 1 (33%)
Country
- South Korea 2 (67%)
- Australia 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Mike Kim
Investment Principal
|
Investment Principal | Total investments: 3 | Find email | |
|
Paul Kang
Founder & Managing Director
|
Founder & Managing Director | Total investments: 0 | Find email | |
|
Tim Kim
Chief Investment Principal
|
Chief Investment Principal | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Your Name Here
|
Your Name Here is a fashion designer that sells t-shirts and jeans. | Series A / Feb 08, 2021 | |
Elastagen
|
Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Elastin is a critical component of tissues in the human body which require the ability to stretch and recoil, such as the skin, lungs, arteries, elastic ligaments. Elastagen hasdeveloped a synthetic version of the elastin protein which is identical to that naturally present in the human body. Elastagen’s platform technology has potential applications in a number of areas including skin rejuvenation, scar remodelling and tissue repair. Elastagen was founded following the acquisition of intellectual property rights to the elastin technology which was developed by Prof Weiss at the University of Sydney. The Company has since successfully attracted capital from a number of leading Australian and overseas life science venture capital groups. Elastagen’s operations have expanded from its Australian base to include production in Europe and clinical operations in the UK. | $8.8M / Series B / Jan 07, 2016 | |
WayWearable
|
WayWearable, a ‘beauty-appliance’ company based in Seoul, Korea, has created the first total personal skincare companion that fits in your purse. The WAY device is the size of a compact powder case, but includes an array of advanced biometric and environmental sensors that it uses to make personalized skincare recommendations through its companionapp. Developed in close consultation with a dermatologist, WAY helps people make smarter skincare decisions that last a lifetime.They recently joined Sparklabs, one of Asia’s top business accelerators, to bring their unique technology product to market and have kicked off an Indiegogo campaign to fund production.Their Vision - WayWearble is dedicated to improving the lives of women, by helping them more effectively manage their skin care routine, and ultimately improve health and well-being. While WAY is a first step, the company has ambitions to continue developing innovative new products that harness advances in technology, with a particular focus on the women’s health and beauty industry.In the future WayWearable will continue to develop their solutions for making more targeted and accurate suggestions of specific products that address the unique skin concerns of women, while providing deeper, personal insights into maintaining a healthy lifestyle. | $1.5M / Dec 17, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does AMOREPACIFIC Ventures invest in?
AMOREPACIFIC Ventures invests primarily in Beauty, Retail and Fashion startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact AMOREPACIFIC Ventures?
Public channels for AMOREPACIFIC Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at AMOREPACIFIC Ventures?
The team at AMOREPACIFIC Ventures includes Mike Kim (Investment Principal), Paul Kang (Founder & Managing Director) and Tim Kim (Chief Investment Principal). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
